baber/WOPTO huggingface dataset:
Patent NZ-503047-A (NZ)
Title: Heat exchanger with pressure reduction of cooling liquid vessel
Inventor: REZNIK DAVID
IPC: A23L3/005
Filed: 1998-06-30
Abstract: A heat exchanger for rapidly cooling a liquid includes a housing (10) for containing a cooling liquid (14), cooling conduits (16) traversing the housing in thermal contact with the cooling liquid and defining a cooling conduit inlet (18) and a cooling conduit outlet (20), and a vacuum pump (12) for reducing the pressure in said housing until the cooling liquid boils whereby a heat transfer coefficient of said cooling liquid is maximized.  A condenser for condensing the vapors or the cooling liquid includes preheating conduits 30 traversing the housing and in thermal contact with the vapors of the cooling liquid.  The preheating conduits define a preheating inlet 32 and a preheating outlet 34.  Liquid food product such as milk is preheated through the conduits 30 from 4 degrees to 74 degrees, and then very rapidly heated in the electroheater 40 to 146 degrees Celsius.  The milk is then very rapidly cooled to 76 degrees in 2 to 3 seconds through cooling conduits 16.
Patent NZ-503474-A (NZ)
Title: Method of inactivating biological contaminants using photosensitizers which are activated by photoradiation
Inventor: CORBIN FRANK
IPC: A61L2/10
Filed: 1999-07-21
Abstract: A method for treating a fluid containing one or more components of blood, blood components and blood constituents in vitro to inactivate microorganisms that may be present therein comprises: a) adding an inactivation effective non-toxic amount of an endogenous alloxazine photosensitizer to the fluid  or endogenously based alloxazine derivative photosensitizer; b) exposing the fluid of step a) to photoradiation sufficient to activate the endogenous photosensitizer whereby the microorganisms are inactivated. The activated endogenous photosensitizer interferes with nucleic acid present in microorganisms in the fluid so that the microorganisms are inactivated. Isoalloxazines and K- and L-vitamins are among the preferred photosensitizers. Systems and apparatuses are also described for decontamination of such fluids using photosensitizers which include means for adding photosensitizer to the fluid; a photopermeable container for exposing the fluid to an amount of photoradiation sufficient to activate the photosensitizer; and a photoradiation source, preferably comprising a light guide, for providing sufficient photoradiation of a type and amount selected to activate the photosensitizer.  Means for controlling photosensitizer concentration in the fluid and rate of fluid flow through the container, including computer processors may be included in such systems.
Patent NZ-504295-A (NZ)
Title: Stabilized aluminium zirconium antiperspirant formulations further containing an amino acid
Inventor: POTECHIN KATHY
IPC: A61Q15/00
Filed: 1998-10-26
Abstract: An aluminum zirconium composition is obtained by stabilizing an aqueous solution of aluminum zirconium based salts with a water soluble amino acid such as glycine in the amount of 1:1.2 to 1:5 of zirconium to amino acid.  The composition is used in cosmetic products such as deodorants.  By reducing the polymerization of small zirconium species with an elevated amount of amino acid(s), the efficacy of the antiperspirant salt is maintained.
Patent NZ-504952-A (NZ)
Title: Nucleic acids encoding an Nmi/Hou-like protein that induce apoptosis useful for treating auto-immune diseases and cancer
Inventor: NOTEBORN MATHIEU HUBERTUS MARI
IPC: A61K38/00
Filed: 1998-12-03
Abstract: The invention relates to activation of apoptosis by means of interference of Hou-like and/or IFP35-like compounds. Also the invention relates to anti-tumor therapies with compounds, which negatively interfere with Hou-like and/or IFP35-like compounds leading to induction of apoptosis, resulting in the elimination of tumor cells. Also the invention relates to therapies for diseases related to aberrant apoptosis induction, such as auto-immune disease. Also the invention describes the diagnosis of cells, which are susceptible to apoptin- or apoptin-like induced apoptosis.
Patent NZ-514043-A (NZ)
Title: Property database
Inventor: INNES STUART MARK
IPC: G06Q30/00
Filed: 2000-02-24
Abstract: A method of operating a security system characterized by the steps of: a) recording independently data on personal property acquired by an entity, and b) allowing at least one party to access at least some of that data to check the veracity of information given separately by another party.
Patent NZ-514381-A (NZ)
Title: Tin-plating or aluminium-plating surface treated steel material with excellent corrosion resistance
Inventor: YAMAGUCHI SHINICHI
IPC: C23C2/08
Filed: 2000-03-17
Abstract: A tin-plating or aluminium-plating surface treated steel material with excellent corrosion resistance, containing an intermetallic compound composed of one or more Group IIa (alkaline earth metal) elements and one or more Group IVb elements in a tin-based plating layer or aluminium-based plating layer on the surface of a steel material. For a tin-based plating layer, the long diameter of the intermetallic compound massive bodies is 1 ìm or greater and the short diameter/long diameter ratio is at least 0.4ìm. For an aluminum-based plating layer, the long diameter of the intermetallic compound massive bodies is 10 ìm or greater and the short diameter/long diameter ratio is at least 0.4 ìm.
Patent NZ-516379-A (NZ)
Title: Multi-layer quiet barrier film comprising a gas and odour barrier layer and an outer layer comprising a blend which comprises an ethylene-vinyl acetate copolymer and an ethylene/alkyl-acrylate or ethylene/alkyl-methacrylate copolymer and a silicone elastomer, and a bag or container made therefrom
Inventor: BUONGIORNO LIVIO
IPC: B32B27/30
Filed: 2001-12-24
Abstract: A multi-layer gas and odour barrier film comprising a gas and odour barrier layer and at least one outer layer made of a blend of an ethylene-vinyl acetate copolymer, an ethylene/alkyl-acrylate/methacrylate copolymer, a silicone elastomer (1-15% of total blend weight). Also disclosed is its use in bags or containers that are used in draining and collecting excretion products from patients whose excretive apparatus has been reconstructed/deviated.
Patent NZ-519146-A (NZ)
Title: 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
Inventor: BECK JAMES P
IPC: A61P25/28
Filed: 2000-11-03
Abstract: A 4-phenyl-substituted terahydroisoquinoline derivative or an oxide thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, or prodrug thereof has the formula I (A-F) wherein: the carbon atom designated * is in the R or S configuration; R1 is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkylalkyl; R2 is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl or haloalkyl; R3 is H, -S(O)nR12, -S(O)nNR11R12, -C(O)R12, -C(O)NR11R12 or optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, -O(phenyl) or -O(benzyl); provided that for compounds of formula IA, R3 is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkylalkyl and provided that for compounds of formula IB, R3 is optionally substituted -O(phenyl) or -O(benzyl) or -OC(O)R13 or -S(O)nR12; R4 is H, halogen, -S(O)nR12, -S(O)nNR11R12, -CN, -C(O)R12, -C(O)NR11R12, -NR11R12, or optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, -O(phenyl) or -O(benzyl); provided that for compounds of formula IC, R4 is optionally substituted alkyl, alkenyl, , alkynyl, cycloalkyl, or cycloalkylalkyl and provided that for compounds of formula ID R4 is optionally substituted -O (phenyl) or -O (benzyl) or -OC(O)R13, -NR11R12 or -S(O)nR12; R5, R6 and R7 in compounds of each of the formulae IA, IB, IC, ID, IE and IF are each independently H, halogen,-OR11, -S(O)nR12, -CN, -C(O)R12, -C(O)NR11R12, -NR11R12, -NR11C (O)R12, -NR11C(O)2R12, NR11C(O)NR12R13, or optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkylalkyl or R5 and R6 or R6 and R7 may be -O-C(R12)2- O-; provided that for compounds of formula IE at least one of R5 or R7 is fluoro, chloro, or methyl; or R5 and R6 are each independently -O-C(R12)2-O- in compounds of the formulae IE, but only where R7 is fluoro, chloro or methyl; or R7 and R6 can independently also be -O-C(R12)2-O- in compounds of the formulae IE, but only where R5 is fluoro, chloro or methyl; R8 is H or halogen provided that for compounds of formula IF, R8 is halogen and R11, R12 and R13 are defined in the specification. The compounds are useful for treating attention deficit disorder, hyperactivity disorder, anxiety, depression, post- traumatic stress disorder, supranuclear palsy, eating disorders, obsessive compulsive disorder, analgesia, nicotine addiction, panic attacks, Parkinsonism and phobia, obesity, late luteal phase syndrome or narcolepsy, cocaine addiction, amphetamine addiction, and psychiatric symptoms anger.
Patent NZ-519354-A (NZ)
Title: Water soluble prodrugs of azole compounds
Inventor: UEDA YASUTSUGU
IPC: C07F9/6518
Filed: 2001-01-16
Abstract: Compounds of formula I are described, wherein: A is the non-hydroxy portion of a triazole antifungal compound of the type containing a secondary or tertiary hydroxy group, and R and R1 are each independently hydrogen or C1-6alkyl. The compounds are used in the manufacture of medicaments for the treatment of fungal infections.
Patent NZ-525999-A (NZ)
Title: Annulus-reinforcing band
Inventor: KUSLICH STEPHEN D
IPC: A61F2/46
Filed: 2001-12-17
Abstract: A pliable band or hoop that is flexible to normal handling, but cannot stretch circumferentially once it has reached the limits of its circumferential length. The band may have a structural portal to be used for filling, or it may simply be constructed of a fabric-like material that allows a fill tube to perforate its walls to allow for filling. In the latter case, the perforated wall tends to self-seal once the fill tube is withdrawn. The band may be flat or tubular in cross-section. However, unlike a balloon, the band does not require either a bottom or a top, as we found that a top and bottom are unnecessary when using a band or hoop to enclose material injected into a reamed out intervertebral space.
Patent NZ-527244-A (NZ)
Title: Improved system and computer software for modelling energy consumption
Inventor: NOURELDIN MAHMOUD BAHY MAHMOUD
IPC: G05B17/02
Filed: 2003-07-28
Abstract: Disclosed is a set of computer executable instructions, stored on a computer readable medium, for modelling the energy consumption of at least one process. Each of the processes uses a plurality of resource streams, with each resource stream having at least one operational attribute. The computer executable instructions are adapted to execute the steps of (a) receiving a set of a range of attribute values from a user for at least one operational attribute of at least one resource stream used by the process, and (b) calculating at least one energy consumption value for the process using the received range or ranges of values. Also disclosed is a method of modeling energy consumption, of at least one process, including a method of calculating global minimum heat energy utility and global minimum cooling energy utility.
Patent NZ-529671-A (NZ)
Title: (Pyrido/thieno)-[f]-oxazepin-5-one derivatives
Inventor: GROVE SIMON JAMES ANTHONY
IPC: A61P17/02
Filed: 2002-06-10
Abstract: Disclosed are (pyrido/thieno)-[f]-oxazepine-5-one derivatives having the general Formula I or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions comprising said derivatives, and to the use of these (pyrido/thieno)-[f]-oxazepine-5-one derivatives in the treatment of neurological diseases and psychiatric disorders which are responsive to enhancement of synaptic responses mediated by AMPA receptors in the central nervous system
Patent NZ-530848-A (NZ)
Title: Polysaccharidic esters of retinoic acid
Inventor: RASTRELLI ALESSANDRO
IPC: A61P37/04
Filed: 2002-07-16
Abstract: Polysaccharidic esters of retinoic acid are disclosed, wherein the hydroxyl groups of the monosaccharidic units of the polysaccharide are partially or totally esterified with retinoic acid. A process to obtain these esters is also disclosed. These polysaccharidic esters of retinoic acid can be used in the pharmaceutical and cosmetic field.
Patent NZ-536171-A (NZ)
Title: Portable vehicle turntable
Inventor: JING MING
IPC: B61J1/02
Filed: 2004-10-28
Abstract: A vehicle turntable comprised of a substantially circular platform member whereby a vehicle positioned thereon may be turned about into any direction horizontally. The means to support the substantially circular platform member is located under the substantially circular platform member. The support means have (i) a substantially ring-shaped frame of which the underneath surface forms at least one cavity with the floor surface on which the vehicle turntable is installed. (ii) at least one set of substantially flexible envelopment means with at least one closeable intake on it located inside the cavity formed by the surface underneath the ring-shaped frame and the floor surface. (iii) filling means for filling the substantially flexible envelopment means. The filling means is substantially coagulable so that the filling means can be injected into the substantially flexible envelopment means through the closeable intake on the substantially flexible envelopment means so that when the filling means is solidified, the filling means will support the ring-shaped frame on the floor surface.
Patent NZ-539540-A (NZ)
Title: Diagnostic tool for an energy conversion appliance
Inventor: COTTRELL BRIAN
IPC: G05B23/02
Filed: 2003-09-23
Abstract: A diagnostic tool and method for monitoring an energy conversion appliance, which may be a heating, ventilating or air conditioning appliance, is disclosed. The method includes the use of a microphone (1) coupled to output means (5) to identify, discriminate and log the acoustic signatures of at least two events of an operating sequence of an appliance. At least one event is of a type including a fluid flow related to combustion, and at least one other event relating to operation of a mechanical or electromechanical device. Individual event occurrences are identified by comparison of a received acoustic signature with stored data to determine whether an event occurrence has occurred in a proper manner and at a correct position in the sequence of a plurality of event occurrences.
Patent NZ-539570-A (NZ)
Title: Load elevator
Inventor: PATTEN SIDNEY ALEXANDER
IPC: B65G69/24
Filed: 2005-04-21
Abstract: An elevating load platform comprises a base member and a load supporting member interconnected by a linkage means that facilitates vertical movement of the load supporting member generally parallel to the base member, and a plurality of coil springs positioned to urge the load supporting member upwardly relative to the base member so that when the load supporting member is laden the coil springs are compressed, and as the load is progressively removed the coil springs urge the load supporting member upwards to thereby maintain the load supporting member at a desired height, the linkage means comprising a pair of spaced scissor linkages interconnected by a central cross member, the plurality of compression springs being positioned in a spaced array interposed between the base member and the cross member.
Patent NZ-540915-A (NZ)
Title: Safety catheter system and method
Inventor: LEINSING KARL R
IPC: A61M25/06
Filed: 2003-12-22
Abstract: A catheter integral with a valved needle-free connector (38) provides a safety catheter device configured to receive a blunt cannula (62) and sharp needle (50) forming an insertion mechanism. The sharp needle is mounted within a needle tube and a control handle (58) is used to slide the sharp needle out of and into the protective needle tube. When the insertion mechanism (34) is mounted to the connector and the control handle is used to slide the sharp needle out of the tube, a blunt cannula first moves into contact with and enters the bore of the valve mechanism of the connector opening it and protecting it from damage that may be caused by the sharp needle. The sharp needle is then extended through the connector and extends out the distal end of the catheter so that a venipuncture procedure may be performed to properly locate the catheter in the patient's circulatory system. Once located, the needle may be retracted into the insertion mechanism, the insertion mechanism disconnected from the connector, and discarded.
Patent NZ-545544-A (NZ)
Title: Silencing of TGF-beta receptor type II expression by sirna
Inventor: KUMAR NALIN M
IPC: C12N/
Filed: 2004-08-10
Abstract: Provided is an siRNA molecule that reduces expression of the TGF beta type II receptor , wherein the siRNA molecule is 19-25 base pairs in length and targets a specified nucleic acid molecule. Further provided is use of the siRNA in the manufacture of a medicament for the treatment of a disorder associated with signalling through the TGF beta type II receptor.
Patent NZ-546830-A (NZ)
Title: Amidoacetonitrile derivatives
Inventor: GAUVRY NOELLE
IPC: C07C255/54
Filed: 2004-11-05
Abstract: Disclosed is a compound of formula I wherein X is Cl, Br or CF3; Y is a single bond, I, S, S(O) or S(O)2; and W is O or S. Also disclosed is the use of the above compound of formula I to control parasites.
Patent NZ-550840-A (NZ)
Title: Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
Inventor: ANDRIES KOENRAAD JOZEF LODEWIJK MARCEL
IPC: A61P31/06
Filed: 2005-05-24
Abstract: Disclosed is the use of a substituted quinoline derivative of formula (Ia) or (Ib), wherein p is 1 to 4, q is 0 to 4, r is 1 to 5, two R6 radicals may be taken together to form a bivalent radical of formula -CH=CH-CH=CH-, R9 is O, or R8 and R9 may together form the radical =N-CH=CH-, and wherein the other substituents are as described in the specification, for treating infections of drug resistant Mycobacterium strains. Also disclosed is a combination of a compound of formula (Ia) or (Ib) as defined above and at least one other antimycobacterial agent.
Patent NZ-553476-A (NZ)
Title: Carrier for enteral administration
Inventor: WEST SIMON MICHAEL
IPC: A23L35/00
Filed: 2005-08-03
Abstract: Disclosed is a method for improving the efficacy and transport of biologically active compounds upon enteral administration; said method comprising the step of combining the biologically active compound with a carrier comprising an effective amount of one or more phosphate derivates of one or more electron transfer agents wherein the carrier and the biologically active compound are different compounds; and wherein the method does not include the step of administration to a human.
Patent NZ-553550-A (NZ)
Title: Energy management in a power generation plant
Inventor: LIVHEN BEN ZION
IPC: F23G5/46
Filed: 2004-11-24
Abstract: A system for energy production by burning solid fossil fuel in a power generation plant includes burners adapted for performing a power generating industrial process where consumption of electric power exhibits periods of different demands. The system comprises an electromagnetic radiation (EMR) drying plant for upgrading the solid fossil fuel. The system also includes a transportation means for moving the upgraded solid fossil fuel to the burners; and/or a storage means suitable for storing a quantity of the solid fossil fuel at least commensurate to daily consumption of the industrial process performed by the system. The EMR drying plant is adapted for performing an EMR drying process for reducing inherent moisture content in the solid fossil fuel by 50% or more.
Patent NZ-554656-A (NZ)
Title: Data management system and method
Inventor: KUMAR VIKRAM
IPC: G06F17/30
Filed: 2007-04-20
Abstract: A method of managing data transfer comprises receiving at an attribute consumer (215) one or more verified attributes associated with a user (205); receiving at an attribute provider (210) a request to assert at least one of the verified attributes; retrieving from computer memory associated with the attribute provider one or more verified attributes specified in the received request; and asserting the verified attribute(s) specified in the received request by transmitting the retrieved attribute(s) to the attribute consumer. Also disclosed is an electronic data management system configured to perform the method of managing data transfer as described above.
Patent NZ-555216-A (NZ)
Title: Treatment of an intestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation
Inventor: CLEVERS JOHANNES CAROLUS
IPC: A61K38/17
Filed: 2005-11-10
Abstract: Disclosed is a use of a Notch pathway inhibitor in the preparation of a medicament for inducing the differentiation of an intestinal adenoma and/or adenocarcinoma cells into a goblet cell thereby treating an intestinal adenoma and/or adenocarcinoma.
Patent NZ-560606-A (NZ)
Title: Fluidic gating device
Inventor: PHELAN ANDREW PETER
IPC: G01N33/50
Filed: 2006-02-22
Abstract: Disclosed is a fluidic gating device having a plurality of test flow paths, each with an end region, the device comprising: a fluid reservoir or sample application region provided upstream from at lease one indicator flow path, wherein the fluid reservoir or sample application region is separated from the indicator flow path/s by at least one obstacle to flow; and wherein the obstacle to flow is operably associated with the end region of a test capillary flow path, such that the presence of the test liquid at the end region of an associated test capillary flow path reduces or abolishes the obstacle to flow, thereby allowing a liquid to flow from the fluid reservoir or sample application region and along an indicator flow path.
Patent NZ-562274-A (NZ)
Title: Knowledge management system for asset managers
Inventor: BYRNE ROGER
IPC: G06Q10/00
Filed: 2005-10-11
Abstract: A knowledge management system for assisting asset owners, managers and operators in managing assets includes a database for storing a plurality of manuals. Each manual includes world's best practice guidelines with regard to an aspect of an asset life cycle. The knowledge management system also includes a performance analysis tool for benchmarking an organisation's performance with regard to each aspect of the asset life cycle to identify areas for improvement; and a benefit assessment component to assist the organisation in determining which improvements have potential to deliver the greatest benefits. The knowledge management system enables the best practice guidelines to be tailored to suit particular organisations and/or asset types.
Patent NZ-566180-A (NZ)
Title: Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
Inventor: JOHANSSON JAN O
IPC: A61K31/352
Filed: 2006-07-28
Abstract: The present disclosure relates to polyphenol-like compounds (particularly the pyrano-pyridin derivatives, pyridin-chromen derivatives, chromen-benzo[d]oxazol derivatives, naphthyridin derivatives, dimethoxyisoquinolin derivatives, isoquinolin-phenol derivatives and morpholinomethyl-quinazolin derivatives), as defined in the specification, that are useful for inhibiting VCAM-1 expression, MCP-1 expression and/or SMC proliferation in a mammal. The disclosed compounds are useful for regulating markers of inflammatory conditions, including vascular inflammation, and for treatment and prevention of inflammatory and cardiovascular diseases and related disease states.
Patent NZ-568999-A (NZ)
Title: Antimicrobial composition comprising EDTA and iodine or ionic silver
Inventor: PERCIVAL STEVEN L
IPC: A01N59/16
Filed: 2006-12-14
Abstract: Disclosed is an antiseptic composition suitable for use on skin and wounds comprising 0.01 percent to 10 percent by weight of a source of an antimicrobial agent selected from the group of iodine or ionic silver and 0.5 to 10 percent by weight of EDTA and wherein the composition has a pH of between 4 and 6.